- Fragments of Bird Flu Virus Found in 1 in 5 Milk Samples
- Clients Got HIV Through ‘Vampire Facial’ Microneedling Treatments
- Take the Stairs & Step Up to Longer Life
- ‘Drug Take Back Day’ is Saturday: Check for Leftover Opioids in Your Home
- Loneliness Can Shorten Lives of Cancer Survivors
- A Stolen Dog Feels Like Losing a Child, Study Finds
- Healthier Hearts in Middle Age Help Black Women’s Brains Stay Strong
- Better Scans Spot Hidden Inflammation in MS Patients
- Which Patients and Surgeries Are ‘High Risk’ for Seniors?
- Vancomycin May Be Losing Strength Against Common Deadly Infection
Kidney Woes Tied to Raised Cancer Risk, Study Finds
Kidney failure and having a kidney transplant may increase the risk for certain types of cancer, a new study suggests.
Poor kidney function and immune system-suppressing drugs may be behind this increased risk, according to Elizabeth Yanik, of the U.S. National Cancer Institute, and colleagues.
For the study, published in the Nov. 12 online edition of the Journal of the American Society of Nephrology, the researchers looked at data from more than 200,000 U.S. kidney transplant candidates and recipients.
Along with finding that these patients are at increased risk for certain types of cancer, the investigators also identified clear patterns of risk associated with different types of treatment. However, the associations seen in the study do not prove cause-and-effect.
The risk of kidney and thyroid cancers was especially high when kidney failure patients were on dialysis. The risk of non-Hodgkin lymphoma, lung cancer, melanoma and certain other types of skin cancers was highest after kidney transplantation. The increased risk after a transplant is probably a result of the drugs that suppress the immune system that patients have to take to prevent rejection of the new kidney, the study authors suggested.
“Our study indicates that the needs of individuals with end-stage renal disease, in terms of cancer prevention and cancer screening, will likely differ over time,” Yanik said in a news release from the American Society of Nephrology.
“Vigilance for kidney cancer and thyroid cancer may be of particular importance while these individuals are on dialysis. Extra consideration for screening for melanoma or lung cancer may be called for while taking immunosuppressant medications following a kidney transplant,” she concluded.
The findings show the need to closely monitor these patients for cancer, Yanik’s team said.
More information
The Urology Care Foundation has more about kidney failure.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.